SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Noora Leppänen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Benzamides, beta Catenin, Cell Plasticity, Homeodomain Proteins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Sigrid Jusélius Foundation, Finnish Cultural Foundation.
Abstract (Originalsprache)
The use of androgen receptor (AR) inhibitors in prostate cancer gives rise to increased cellular lineage plasticity resulting in resistance to AR-targeted therapies. In this study, we examined the chromatin landscape of AR-positive prostate cancer cells post-exposure to the AR inhibitor enzalutamide. We identified a novel regulator of cell plasticity, the homeobox transcription factor SIX2, whose motif is enriched in accessible chromatin regions after treatment. Depletion of SIX2 in androgen-independent PC-3 prostate cancer cells induced a switch from a stem-like to an epithelial state, resulting in reduced cancer-related properties such as proliferation, colony formation, and metastasis both in vitro and in vivo. These effects were mediated through the downregulation of the Wnt/β-catenin signalling pathway and subsequent reduction of nuclear β-catenin. Collectively, our findings provide compelling evidence that the depletion of SIX2 may represent a promising strategy for overcoming the cell plasticity mechanisms driving antiandrogen resistance in prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
- A.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
- Heart Center and Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
ORCID-Profile: Seppo Ylä-Herttuala, Ilkka Paatero, Ville Paakinaho, Kirsi Ketola
Förderung
- Research Council of Finland
- Sigrid Jusélius Foundation
- Finnish Cultural Foundation
- North Savo Regional Fund
- Cancer Foundation Finland
Zitieren
APA
Leppänen, N., Kaljunen, H., Takala, E., Kaarijärvi, R., Mäkinen, P. I., Ylä-Herttuala, S., Paatero, I., Paakinaho, V., & Ketola, K. (2024). SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae206
Vancouver
Leppänen N, Kaljunen H, Takala E, Kaarijärvi R, Mäkinen PI, Ylä-Herttuala S, et al. SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae206
BibTeX
@article{Leppnen2024,
author = {Leppänen, Noora and Kaljunen, Heidi and Takala, Eerika and Kaarijärvi, Roosa and Mäkinen, Petri I and Ylä-Herttuala, Seppo and Paatero, Ilkka and Paakinaho, Ville and Ketola, Kirsi},
title = {SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae206}
}
EUVIMED